{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:58Z","timestamp":1792382938698,"version":"4.4.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40620-017-0397-7","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T11:06:34Z","timestamp":1491995194000},"page":"629-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease"],"prefix":"10.1093","volume":"30","author":[{"given":"Ziad","family":"Massy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Drueke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"397_CR1","unstructured":"Kidney Disease-Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl:S1\u2013S130"},{"key":"397_CR2","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013201","journal-title":"Am J Kidney Dis"},{"key":"397_CR3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moyses RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771\u2013777","journal-title":"Kidney Int"},{"key":"397_CR4","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26:1368\u20131376","journal-title":"J Bone Miner Res"},{"key":"397_CR5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D\u2019Haese PC, Drueke TB, Du H, Manley T et al (2016) Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67:559\u2013566","journal-title":"Am J Kidney Dis"},{"key":"397_CR6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder. Kidney Int 43:436\u2013442","journal-title":"Kidney Int"},{"key":"397_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","volume":"11","author":"G Coen","year":"1996","unstructured":"Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F (1996) Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transpl 11:813\u2013819","journal-title":"Nephrol Dial Transpl"},{"key":"397_CR8","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378","journal-title":"Kidney Int"},{"key":"397_CR9","first-page":"289","volume":"36","author":"FC Barreto","year":"2014","unstructured":"Barreto FC, Barreto DV, FernandesCanziani ME, Tomiyama C, Higa A, Mozar A, Glorieux G, Vanholder R, Massy ZA, BarbosaDeCarvalho A (2014) Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients. J Braz Nefrol 36:289\u2013296","journal-title":"J Braz Nefrol"},{"key":"397_CR10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.kint.2016.04.024","volume":"90","author":"NA Dhayat","year":"2016","unstructured":"Dhayat NA, Ackermann D, Pruijm M, Ponte B, Ehret G, Guessous I, Leichtle AB, Paccaud F, Mohaupt M, Fiedler GM et al (2016) Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int 90:648\u2013657","journal-title":"Kidney Int"},{"key":"397_CR11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/jcem.84.2.5485","volume":"84","author":"MH Lafage-Proust","year":"1999","unstructured":"Lafage-Proust MH, Combe C, Barthe N, Aparicio M (1999) Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction. J Clin Endocrinol Metab 84:512\u2013519","journal-title":"J Clin Endocrinol Metab"},{"key":"397_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.12.029","author":"FG Graciolli","year":"2017","unstructured":"Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moys\u00e9s RM (2017) The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Kidney Int. doi:\n                        10.1016\/j.kint.2016.12.029","journal-title":"Kidney Int"},{"key":"397_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Drueke","year":"2016","unstructured":"Drueke TB, Massy ZA (2016) Changing bone patterns with progression of chronic kidney disease. Kidney Int 89:289\u2013302","journal-title":"Kidney Int"},{"key":"397_CR14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.1997.12.6.958","volume":"12","author":"F Cosman","year":"1997","unstructured":"Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, Lindsay R, Parisien M (1997) Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 12:958\u2013966","journal-title":"J Bone Miner Res"},{"key":"397_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2009.04.237","volume":"45","author":"L Yan","year":"2009","unstructured":"Yan L, Schoenmakers I, Zhou B, Jarjou LM, Smith E, Nigdikar S, Goldberg GR, Prentice A (2009) Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration. Bone 45:238\u2013245","journal-title":"Bone"},{"key":"397_CR16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, Freedman BI, Monier-Faugere MC, Malluche H, Hruska KA (2014) CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25:1760\u20131773","journal-title":"J Am Soc Nephrol"},{"key":"397_CR17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","volume":"27","author":"Y Sabbagh","year":"2012","unstructured":"Sabbagh Y, Graciolli FG, O\u2019Brien S, Tang W, dos Reis LM, Ryan S, Phillips L, Boulanger J, Song W, Bracken C et al (2012) Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27:1757\u20131772","journal-title":"J Bone Miner Res"},{"key":"397_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","volume":"30","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chen NX, Newman CL, Organ JM, Kneissel M, Kramer I, Gattone VH 2nd, Allen MR (2015) Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30:499\u2013509","journal-title":"J Bone Miner Res"},{"key":"397_CR19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S8756-3282(99)00169-6","volume":"25","author":"J Bover","year":"1999","unstructured":"Bover J, Jara A, Trinidad P, Rodriguez M, Felsenfeld AJ (1999) Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus. Bone 25:279\u2013285","journal-title":"Bone"},{"key":"397_CR20","doi-asserted-by":"crossref","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","volume":"8","author":"JC Ferreira","year":"2013","unstructured":"Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, Dos Reis LM, Graciolli FG, Oliveira EC, Liu S, Sabbagh Y et al (2013) Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease\u2014role of sclerostin? PLoS One 8:e79721","journal-title":"PLoS One"},{"key":"397_CR21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfr254","volume":"27","author":"IG Nikolov","year":"2012","unstructured":"Nikolov IG, Joki N, Nguyen-Khoa T, Guerrera IC, Maizel J, Benchitrit J, Machado dos Reis L, Edelman A, Lacour B, Jorgetti V et al (2012) Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice. Nephrol Dial Transpl 27:505\u2013513","journal-title":"Nephrol Dial Transpl"},{"key":"397_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","volume":"56","author":"H Tanaka","year":"2013","unstructured":"Tanaka H, Iwasaki Y, Yamato H, Mori Y, Komaba H, Watanabe H, Maruyama T, Fukagawa M (2013) p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways. Bone 56:347\u2013354","journal-title":"Bone"},{"key":"397_CR23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","volume":"71","author":"T Nii-Kono","year":"2007","unstructured":"Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M, Yamato H, Kurokawa K, Fukagawa M (2007) Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71:738\u2013743","journal-title":"Kidney Int"},{"key":"397_CR24","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","volume":"27","author":"A Mozar","year":"2012","unstructured":"Mozar A, Louvet L, Godin C, Mentaverri R, Brazier M, Kamel S, Massy ZA (2012) Indoxyl sulphate inhibits osteoclast differentiation and function. Nephrol Dial Transpl 27:2176\u20132181","journal-title":"Nephrol Dial Transpl"},{"key":"397_CR25","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","volume":"21","author":"Y Iwasaki","year":"2006","unstructured":"Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A, Motojima M, Fukagawa M (2006) Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats. Nephrol Dial Transpl 21:2768\u20132774","journal-title":"Nephrol Dial Transpl"},{"key":"397_CR26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","volume":"57","author":"Y Iwasaki","year":"2013","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Shimoda H, Fukagawa M (2013) Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease. Bone 57:477\u2013483","journal-title":"Bone"},{"key":"397_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.01.023","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, Sugatani T, Agapova O, Fang Y (2017) The chronic kidney disease\u2014mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. doi:\n                        10.1016\/j.bone.2017.01.023","journal-title":"Bone"},{"key":"397_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbadis.2016.10.027","volume":"1863","author":"V Metzinger-Le Meuth","year":"2017","unstructured":"Metzinger-Le Meuth V, Burtey S, Maitrias P, Massy ZA, Metzinger L (2017) microRNAs in the pathophysiology of CKD-MBD: Biomarkers and innovative drugs. Biochim Biophys Acta 1863:337\u2013345","journal-title":"Biochim Biophys Acta"},{"key":"397_CR29","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/jbmr.459","volume":"26","author":"R Prisby","year":"2011","unstructured":"Prisby R, Guignandon A, Vanden-Bossche A, Mac-Way F, Linossier MT, Thomas M, Laroche N, Malaval L, Langer M, Peter ZA et al (2011) Intermittent PTH(1\u201384) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites. J Bone Miner Res 26:2583\u20132596","journal-title":"J Bone Miner Res"},{"key":"397_CR30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS (2012) Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int 81:640\u2013650","journal-title":"Kidney Int"},{"key":"397_CR31","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/jbmr.523","volume":"26","author":"DA Towler","year":"2011","unstructured":"Towler DA (2011) Skeletal anabolism, PTH, and the bone-vascular axis. J Bone Miner Res 26:2579\u20132582","journal-title":"J Bone Miner Res"},{"key":"397_CR32","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.2014060543","volume":"26","author":"K Yang","year":"2015","unstructured":"Yang K, Wang C, Nie L, Zhao X, Gu J, Guan X, Wang S, Xiao T, Xu X, He T et al (2015) Klotho protects against indoxyl sulphate-induced myocardial hypertrophy. J Am Soc Nephrol 26:2434\u20132446","journal-title":"J Am Soc Nephrol"},{"key":"397_CR33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40620-016-0339-9","volume":"29","author":"C Carvalho","year":"2016","unstructured":"Carvalho C, Alves CM, Frazao JM (2016) The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives. J Nephrol 29:617\u2013626","journal-title":"J Nephrol"},{"key":"397_CR34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2014.425","volume":"87","author":"M Ketteler","year":"2015","unstructured":"Ketteler M, Elder GJ, Evenepoel P, Ix JH, Jamal SA, Lafage-Proust MH, Shroff R, Thadhani RI, Tonelli MA, Kasiske BL et al (2015) Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a kidney disease: improving global outcomes controversies conference. Kidney Int 87:502\u2013528","journal-title":"Kidney Int"},{"key":"397_CR35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40620-015-0202-4","volume":"29","author":"M Gallieni","year":"2016","unstructured":"Gallieni M, De Luca N, Santoro D, Meneghel G, Formica M, Grandaliano G, Pizzarelli F, Cossu M, Segoloni G, Quintaliani G et al (2016) Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study. J Nephrol 29:71\u201378","journal-title":"J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-017-0397-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:06Z","timestamp":1777564626000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/30\/5\/629\/8371295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1007\/s40620-017-0397-7","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}